Mucosal immune responses

被引:77
|
作者
Acheson, DWK [1 ]
Luccioli, S [1 ]
机构
[1] US FDA, CFSAN, DHSS, College Pk, MD 20740 USA
关键词
mucosal immunity; intestinal epithelial cells; food-borne pathogens; gut-associated lymphoid tissue; follicle associated epithelia;
D O I
10.1016/j.bpg.2003.11.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The host gastrointestinal tract is exposed to countless numbers of foreign antigens and has embedded a unique and complex network of immunological and non-immunological mechanisms, often termed the gastrointestinal 'mucosal barrier', to protect the host from potentially harmful pathogens while at the same time 'tolerating' other resident microbes to allow absorption and utilization of nutrients. Of the many important roles of this barrier, it is the distinct responsibility of the mucosal immune system to sample and discriminate between harmful and beneficial antigens and to prevent entry of food-borne pathogens through the gastrointestinal (GI) tract. This system comprises an immunological network termed the gut-associated lymphoid tissue (GALT) that consists of unique arrangements of B cells, T cells and phagocytes which sample luminal antigens through specialized epithelia termed the follicle associated epithelia (FAE) and orchestrate co-ordinated molecular responses between immune cells and other components of the mucosal barrier. Certain pathogens have developed ways to bypass and/or withstand defence by the mucosal immune system to establish disease in the host. Some 'opportunistic' pathogens (such as Clostridium difficile) take advantage of host or other factors (diet, stress, antibiotic use) which may alter or weaken the response of the immune system. Other pathogens have developed mechanisms for invading gastrointestinal epithelium and evading phagocytosis/destruction by immune system defences. Once cellular invasion occurs, host responses are activated to limit local mucosal damage and repel the foreign influence. Some pathogens (Shigella spp, parasites and viruses) primarily establish localized disease while others (Salmonella, Yersinia, Listeria) use the lymphatic system to enter organs or the bloodstream and cause more systemic illness. In some cases, pathogens (Helicobacter pylori and Salmonella typhi) colonize the GI tract or associated lymphoid structures for extended periods of time and these persistent pathogens may also be potential triggers for other chronic or inflammatory diseases, including inflammatory bowel disease and malignancies. The ability of certain pathogens to avoid or withstand the host's immune assault and/or utilize these host responses to their own advantage (i.e. enhance further colonization) will dictate the pathogen's success in promoting illness and furthering its own survival.
引用
收藏
页码:387 / 404
页数:18
相关论文
共 50 条
  • [11] The role of sympathetic innervation of the gut in regulating mucosal immune responses
    Gonzalez-Ariki, S
    Husband, AJ
    BRAIN BEHAVIOR AND IMMUNITY, 1998, 12 (01) : 53 - 63
  • [12] MONITORING INTERNAL TRAINING LOAD AND MUCOSAL IMMUNE RESPONSES IN FUTSAL ATHLETES
    Moreira, Alexandre
    de Moura, Nivaldo Ribeiro
    Coutts, Aaron
    Costa, Eduardo Caldas
    Kempton, Thomas
    Aoki, Marcelo Saldanha
    JOURNAL OF STRENGTH AND CONDITIONING RESEARCH, 2013, 27 (05) : 1253 - 1259
  • [13] Critical roles of bile acids in regulating intestinal mucosal immune responses
    Sun, Ruicong
    Xu, Chunjin
    Feng, Baisui
    Gao, Xiang
    Liu, Zhanju
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [14] Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants
    Chin, J
    SanGil, F
    Novak, M
    Eamens, G
    Djordjevic, S
    Simecka, J
    Duncan, J
    Mullbacher, A
    JOURNAL OF BIOTECHNOLOGY, 1996, 44 (1-3) : 13 - 19
  • [15] Antigen sampling across epithelial barriers and induction of mucosal immune responses
    Neutra, MR
    Pringault, E
    Kraehenbuhl, JP
    ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 275 - 300
  • [16] Mouse and human Notch-1 regulate mucosal immune responses
    Mathern, D. R.
    Laitman, L. E.
    Hovhannisyan, Z.
    Dunkin, D.
    Farsio, S.
    Malik, T. J.
    Roda, G.
    Chitre, A.
    Iuga, A. C.
    Yeretssian, G.
    Berin, M. C.
    Dahan, S.
    MUCOSAL IMMUNOLOGY, 2014, 7 (04) : 995 - 1005
  • [17] PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
    Rioux, Gervais
    Mathieu, Claudia
    Russell, Alexis
    Bolduc, Marilene
    Laliberte-Gagne, Marie-Eve
    Savard, Pierre
    Leclerc, Denis
    JOURNAL OF NANOBIOTECHNOLOGY, 2014, 12
  • [18] Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization
    VanCott, JL
    Kobayashi, T
    Yamamoto, M
    Pillai, S
    McGhee, JR
    Kiyono, H
    VACCINE, 1996, 14 (05) : 392 - 398
  • [19] PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
    Gervais Rioux
    Claudia Mathieu
    Alexis Russell
    Marilène Bolduc
    Marie-Eve Laliberté-Gagné
    Pierre Savard
    Denis Leclerc
    Journal of Nanobiotechnology, 12
  • [20] Mucosal Immune Responses against Live Newcastle Disease Vaccine in Immunosuppressed Chickens
    Yan, Zhengui
    Du, Yijun
    Zhao, Qingyou
    Fan, Ruifeng
    Guo, Wenlong
    Ma, Rongde
    Wang, Xinjian
    Zhu, Ruiliang
    PAKISTAN VETERINARY JOURNAL, 2011, 31 (04) : 280 - 286